Industry Supported Sessions

SATURDAY, OCTOBER 23, 2021


12:30-13:30    South Hall 1

Industry symposium 1

AstraZeneca_RGB_H_COL

Under The Microscope: Expert perspectives on

personalised medicine in newly diagnosed advanced ovarian cancer

Organised by AstraZeneca

Chair: Andreas du Bois (Germany)

12:30-12:35        Chair’s welcome and introductions
Andreas du Bois (Germany)

12:35-12:50        Bringing BRCA into focus: Key considerations for implementing personalised medicine based on BRCA status
Susana Banerjee (United Kingdom)

12:50-13:05        Placing HRD under the lens: The role of genomic instability testing in optimising patient car
Thomas Herzog (USA)

13:05-13:10       Summary and meeting close
Andreas du Bois (Germany)

13:10-13:30        Panel discussion and Q&A

15:00-16:00   South Hall 1

Industry symposium 3

GSK_Logo-500x500

Data-driven decision-making in first-line advanced ovarian cancer:

an interactive patient-based approach

Organised by GSK

Chair: David Cibula (Czech Republic)

 

15:00-15:05        First-line maintenance therapy and the treatment landscape in advanced ovarian cancer             
David Cibula (Czech Republic)

15:05-15:50        Patient case profiles and guided decision-making
Susana Banerjee (United Kingdom), Kathleen Moore (USA)

15:50-16:00        Panel discussion: putting it into perspective

 

15:00-16:00   South Hall 2

Industry symposium 4

Seagen Logo_RGB

New Frontiers in Treating Metastatic Cervical Cancer
From Revolutionary Molecules to Clinical Therapies

Organised by Seagen

Chair: Ignace Vergote (Belgium)

 

15:00-15:05       Introduction
Ignace Vergote (Belgium)

15:05-15:20       Perspectives on current treatment landscape for r/m CC
Christian Marth (Austria), Ignace Vergote (Belgium)

15:20-15:35       Experts discuss future treatment modalities for r/m CC
Isabelle Ray-Coquard (France), Mansoor Raza Mirza (Denmark)

15:35-15:50       Can ADCs change r/m CC treatment landscape?
Domenica Lorusso (Italy), Ignace Vergote (Belgium)

15:50-16:00        Live Q&A
                               

SUNDAY, OCTOBER 24, 2021


 

13:00-14:00  South Hall 1  

Industry symposium 5 

Mersana logo - CMYK - vector - JPEG (002) (002)

Antibody Drug Conjugates in Treating Recurrent Ovarian Cancer:

The Next Generation – A Focus on NaPi2b

Organised by Mersana Therapeutics

Chair: Nicole Concin (Austria)

 

13:00-13:20        The Unmet Medical Need and Antibody Drug Conjugate Targets in Platinum-Resistant Ovarian Cancer (PROC)
Nicole Concin (Austria)

13:20-13:40        Antibody Drug Conjugates (ADCs) – Structure, Key Properties, and Mechanism of Action
David Cibula (Czech Republic)

13:40-14:00        NaPi2b-ADC biological rationale and clinical development of upifitamab rilsodotin (UpRi, XMT- 1536) and lifastuzumab vedotin (LIFA)
Isabelle Ray-Coquard (France)

13:00-13:30    South Hall 2   

Industry symposium 6

Ethicon_new_logo_1

Johnson & Johnson Digital Surgical Ecosystem

Organised by Ethicon

Chairs: Giovanni Antonio Tommaselli (Italy) and Philippe Grange (Germany)

15:30-16:30  South Hall 1

Industry symposium 7  

GSK_Logo-500x500

Molecular Profiling and Immunotherapy in Endometrial Cancer Treatment

Organised by GSK

Chair: Mansoor Raza Mirza (Denmark)

 

15:30-15:35        Welcome and Introduction
Mansoor Raza Mirza (Denmark)

15:35-15:50        Key Updates to EC Treatment Guidelines: Molecular Profiling
Nicole Concin (Austria)

15:50-16:00        The Role of Immunotherapy in Patients with EC
Mansoor Raza Mirza (Denmark)

16:00-16:15        The Future of Immunotherapy in EC
Bhavana Pothuri (USA)

16:15-16:30        Q&A

 

15:30-16:30   South Hall 2

Industry symposium 8

INTUITIVE logo blue on white 553x305px

Perspectives on robotic assisted surgery in Gynecology Oncology during COVID times

Organised by Intuitive

Chair: Giovanni Scambia (Italy)

 

15:30-15:45        The Intuitive Ecosystem – What Covid helped us to achieve
Myriam Curet (USA)

15:45-16:05        Robotic GYN surgery during Covid, the Liverpool Women’s Experience
Mohamed Otify (United Kingdom)

16:05-16:25        Tips and tricks to support a low-impact robotic surgery in Gynecology
Jordi Ponce (Spain)

16:25-16:30         Q&A

 

 

ONLINE PART OF THE CONGRESS

SATURDAY, OCTOBER 30, 2021


 

10:00-10:30   Channel 1

Technology forum

Organised by Intuitive

INTUITIVE logo blue on white 553x305px

Digital Integration of the OR: Enabling the future with a comprehensive, connected ecosystem

Speaker: Brian Miller (Chief Digital Officer, Intuitive)

 

 

ONLINE PART OF THE CONGRESS

SUNDAY, OCTOBER 31, 2021


 

11:30-12:00    Channel 1

Sponsored Talk

Organised by Intuitive

INTUITIVE logo blue on white 553x305px

Endometrial Cancer Surgery - Considerations Around Obese and Elderly Patients

Speaker: Walter Gotlieb (Canada)

You may also like

ESGO_2015_24102015_0296_WEB

Reasons to Attend

on demand

ESGO 2021

100+ Lectures on-demand

 

Explore it Now!

prague

Photo Gallery

Great moments from ESGO 2021!

 

View it Now!

register

Registration